A citation-based method for searching scientific literature

G M Pitari, L V Zingman, D M Hodgson, A E Alekseev, S Kazerounian, M Bienengraeber, G Hajnóczky, A Terzic, S A Waldman. Proc Natl Acad Sci U S A 2003
Times Cited: 115



L Zhang, W Zhou, V E Velculescu, S E Kern, R H Hruban, S R Hamilton, B Vogelstein, K W Kinzler. Science 1997
Times Cited: 1140




List of shared articles



Times cited

Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
John C Flickinger, Jeffrey A Rappaport, Joshua R Barton, Trevor R Baybutt, Amanda M Pattison, Adam E Snook, Scott A Waldman. Biomark Med 2021
0

Pathogenic roles of altered calcium channels and transporters in colon tumorogenesis.
Xiaoxu Yang, Jun Lou, Weixi Shan, Yanxia Hu, Qian Du, Qiushi Liao, Rui Xie, Jingyu Xu. Life Sci 2019
1


Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
Allison A Aka, Jeff A Rappaport, Amanda M Pattison, Takami Sato, Adam E Snook, Scott A Waldman. Expert Rev Clin Pharmacol 2017
17

ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice.
Peng Li, Jieru E Lin, Adam E Snook, Scott A Waldman. Toxins (Basel) 2017
8

Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
Jieru E Lin, Francheska Colon-Gonzalez, Erik Blomain, Gilbert W Kim, Amanda Aing, Brian Stoecker, Justin Rock, Adam E Snook, Tingting Zhan, Terry M Hyslop,[...]. Cancer Res 2016
38

The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
Chantell Wilson, Jieru E Lin, Peng Li, Adam E Snook, Jianping Gong, Takahiro Sato, Chengbao Liu, Melanie A Girondo, Hallgeir Rui, Terry Hyslop,[...]. Cancer Epidemiol Biomarkers Prev 2014
33

Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.
Ahmara V Gibbons, Jieru E Lin, Gilbert W Kim, Glen P Marszalowicz, Peng Li, Brian A Stoecker, Erik S Blomain, Satish Rattan, Adam E Snook, Stephanie Schulz,[...]. Cancer Res 2013
16

GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome?
P Li, J E Lin, G P Marszlowicz, M A Valentino, C Chang, S Schulz, G M Pitari, Scott A Waldman. Drug News Perspect 2009
13

Can colorectal cancer be prevented or treated by oral hormone replacement therapy?
P Li, J E Lin, S Schulz, G M Pitari, S A Waldman. Curr Mol Pharmacol 2009
9

Colorectal cancer is a paracrine deficiency syndrome amenable to oral hormone replacement therapy.
P Li, J E Lin, A E Snook, A V Gibbons, D S Zuzga, S Schulz, G M Pitari, S A Waldman. Clin Transl Sci 2008
17

Sex modulates intestinal transformation by the tumor-suppressor GCC.
Peng Li, Stephanie Schulz, Giovanni M Pitari, Scott A Waldman. Clin Transl Sci 2008
0

Sex modulates intestinal transformation by the tumor-suppressor GCC.
Peng Li, Stephanie Schulz, Giovanni M Pitari, Scott A Waldman. Clin Transl Sci 2008
0

Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Peng Li, Stephanie Schulz, Alessandro Bombonati, Juan P Palazzo, Terry M Hyslop, Yihuan Xu, Amy A Baran, Linda D Siracusa, Giovanni M Pitari, Scott A Waldman. Gastroenterology 2007
101

The paracrine hormone hypothesis of colorectal cancer.
G M Pitari, P Li, J E Lin, D Zuzga, A V Gibbons, A E Snook, S Schulz, S A Waldman. Clin Pharmacol Ther 2007
44

Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine.
Peng Li, Jieru E Lin, Inna Chervoneva, Stephanie Schulz, Scott A Waldman, Giovanni M Pitari. Am J Pathol 2007
85